Coca-Cola Co. Revenue Misses Expectations
Actavis agreed to buy rival drug maker Forest Labs for $25 billion. Plus, key stocks to watch include Coca-Cola and Tesla. MarketWatch’s Victor Reklaitis joins the News Hub. Photo: The Coca-Cola Company.
“Coca-Cola Co. Revenue Misses Expectations” is categorized as “business”. This video was licensed from Grab Networks. For additional video content, click the “video” tab at the top of this page.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.